Predictive indicators of successful tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia

Clinical trials have demonstrated that some patients with chronic myeloid leukemia (CML) treated for several years with tyrosine kinase inhibitors (TKIs) who have maintained a molecular response can successfully discontinue treatment without relapsing. Treatment free remission (TFR) can be reached b...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:World J Clin Oncol
Egile Nagusiak: Stuckey, Ruth, López-Rodríguez, Juan Francisco, Sánchez-Sosa, Santiago, Segura-Díaz, Adrián, Sánchez-Farías, Nuria, Bilbao-Sieyro, Cristina, Gómez-Casares, María Teresa
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Baishideng Publishing Group Inc 2020
Gaiak:
Minireviews
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7769711/
https://ncbi.nlm.nih.gov/pubmed/33437662
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5306/wjco.v11.i12.996
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak